Acute Myeloid Leukemia (Paperback, 1st ed. 2021)

This book, written by a team of leading experts, provides a comprehensive overview of acute myeloid leukemia (AML), the most frequent acute leukemia in adults. The opening chapters present current knowledge of epidemiology, etiologic factors, and the pathogenesis and molecular development of AML. Detailed guidance is offered on laboratory and clinical diagnostic workup and disease classification, and the patient- and disease-related factors that determine prognosis and treatment allocation are identified. On the basis of these general considerations, initial treatments in patients considered fit for intensive treatment and in older and co-morbid patients are reviewed, and the available relapse treatment strategies, explained. For all clinical scenarios, the most recent data on the optimal use of newly approved agents in different AML subgroups are presented. Separate chapters address the treatment of acute promyelocytic leukemia, current practice of allogeneic stem cell transplantation, and special clinical situations. Finally, promising approaches in drug development, current standards and challenges in assessment of measurable residual disease, immune approaches, and ideas for innovative trial designs are considered.

General

Imprint:	Springer Nature Switzerland AG
Country of origin:	Switzerland
Series:	Hematologic Malignancies
Release date:	May 2022
First published:	2021
Editors:	Christoph Roellig • Gert J. Ossenkoppele
Dimensions:	254 x 178mm (L x W)
Format:	Paperback
Pages:	358
Edition:	1st ed. 2021
ISBN-13:	978-3-03-072678-2
Categories:	Books > Medicine > Clinical & internal medicine > Haematology Promotions
LSN:	3-03-072678-9
Barcode:	9783030726782

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!